CPhI Update

Sep 30, 2016
By Pharmaceutical Technology Editors
Tapemark, a full-service CDMO specializing in transdermal, oral thin film, and topical drug-delivery technologies, is exhibiting at CPhI.
Sep 29, 2016
By Pharmaceutical Technology Editors
The next decade of drug development will depend on better ways of storing, using, and analyzing data, says CPhI advisor Bikash Chatterjee, president and chief science officer of Pharmatech Associates. But each of the following must be optimized: volume, variety, velocity, veracity, and value.
Sep 29, 2016
By Pharmaceutical Technology Editors
Containing costs and improving compliance will be crucial to ensuring the growth of generic pharmaceuticals in the future, says Dilip Shah, CEO of Vision Consulting Group, in CPhI’s 2016 Annual Report, which will be formally issued at CPhI 2016 in Barcelona.
Sep 29, 2016
By Pharmaceutical Technology Editors
Sharp will present alongside Tracelink, Systech, Covectra, and Domino during CPhI Worldwide.
Sep 29, 2016
By Pharmaceutical Technology Editors
The CDMO has acquired a new building to expand its high-containment manufacturing and development operations.
Sep 29, 2016
By Pharmaceutical Technology Editors
Three-dimensional (3D) printing, which is a type of additive manufacturing (AM), enables fabrication of specialty drugs and medical devices, said Emil Ciurczak, Doramaxx Consulting and CPhI expert panel member, in the 2016 CPhI Annual Industry Report.
Sep 29, 2016
By Pharmaceutical Technology Editors
Alan Sheppard, Principal, Global Generics at IMS Health and CPhI expert panel member, discusses generic medicine opportunities in the 2016 CPhI Annual Industry Report.
Sep 28, 2016
By Pharmaceutical Technology Editors
The current approach of classifying process parameters and quality attributes as critical or non-critical is too simplistic to adequately reflect current science and risk-based approaches to product quality.
Sep 28, 2016
By Pharmaceutical Technology Editors
The choice of metrics used to measure the performance of a pharmaceutical operation are crucial, and should be systems oriented.
Sep 27, 2016
By Pharmaceutical Technology Editors
Pharma’s lack of manufacturing innovation is its biggest shortcoming; but like any other business, investment in this area will need to be justified.
native1_300x100
lorem ipsum